Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Consensus and Guidelines · September 11, 2022

2022 ACC ECDP on the Role of Nonstatin Therapies for LDL-C Lowering in the Management of ASCVD Risk

Journal of the American College of Cardiology

 

Additional Info

Journal of the American College of Cardiology
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
J Am Coll Cardiol 2022 Aug 23;[EPub Ahead of Print], DM Lloyd-Jones, PB Morris, CM Ballantyne, KK Birtcher, AM Covington, SM DePalma, MB Minissian, CE Orringer, SC Smith, AA Waring, JT Wilkins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading